Pancreatitis

Pancreatitis: High-Yield Study Guide for Medical Students

Definition

Pancreatitis is inflammation of the pancreas, classically divided into:

• Acute pancreatitis (AP): sudden, reversible inflammatory process of the pancreas that may involve peripancreatic tissues and distant organ systems.
• Chronic pancreatitis (CP): long-standing inflammation leading to irreversible parenchymal destruction, fibrosis, and loss of exocrine and endocrine function.

Acute pancreatitis is usually diagnosed when at least 2 of 3 criteria are present: characteristic abdominal pain, serum amylase and/or lipase > 3× upper limit of normal, and/or imaging findings consistent with pancreatitis.

Epidemiology

Pancreatitis is a common cause of hospital admission for gastrointestinal disease.

• Acute pancreatitis: incidence roughly 30–50 per 100,000 person-years in many populations; most common causes are gallstones and alcohol.
• Chronic pancreatitis: lower incidence, strongly associated with long-term alcohol use in many regions, with increasing recognition of genetic and autoimmune causes.
• Acute pancreatitis shows a slight male predominance when alcohol-related; gallstone pancreatitis is more common in females.
• Chronic pancreatitis often presents in middle age but can occur earlier in hereditary forms.

Etiology and Risk Factors

Common causes are remembered by the mnemonic “I GET SMASHED”, especially relevant for acute pancreatitis:

• I – Idiopathic
• G – Gallstones (most common cause in many series)
• E – Ethanol (alcohol)
• T – Trauma (especially blunt abdominal trauma)
• S – Steroids
• M – Mumps and other infections (e.g., coxsackievirus, hepatitis viruses)
• A – Autoimmune (e.g., IgG4-related disease)
• S – Scorpion sting (notably Tityus trinitatis in some regions)
• H – Hypertriglyceridemia (> 1000 mg/dL) and Hypercalcemia
• E – ERCP (post-ERCP pancreatitis)
• D – Drugs (e.g., azathioprine, didanosine, valproate, thiazides, furosemide, ACE inhibitors, mesalamine, pentamidine)

Chronic pancreatitis is most commonly due to chronic alcohol use, but other causes include genetic (e.g., PRSS1, SPINK1, CFTR mutations), autoimmune pancreatitis, obstructive causes (pancreatic duct strictures, tumors), and idiopathic disease.

Pathophysiology

Acute Pancreatitis

Acute pancreatitis is driven by inappropriate intrapancreatic activation of digestive enzymes, particularly trypsin, leading to autodigestion and inflammation.

• Obstruction of the pancreatic duct (e.g., gallstones) or direct acinar cell injury (e.g., alcohol, drugs, ischemia) triggers premature conversion of trypsinogen to trypsin.
• Activated enzymes damage acinar cells, blood vessels, and surrounding tissues, causing edema, fat necrosis, hemorrhage, and inflammatory cell infiltration.
• Pro-inflammatory cytokines (e.g., TNF-α, IL-1, IL-6) and chemokines are released, which can lead to a systemic inflammatory response, capillary leak, hypotension, and multiorgan failure in severe cases.
• In severe necrotizing pancreatitis, areas of pancreatic tissue undergo necrosis, which may become infected, significantly increasing morbidity and mortality.

Chronic Pancreatitis

Chronic pancreatitis is characterized by recurrent or persistent inflammation with progressive fibrosis and loss of functional pancreatic parenchyma.

• Repeated injury (often from chronic alcohol exposure) leads to sustained activation of stellate cells and fibroblasts with collagen deposition and scarring.
• Pancreatic ducts may become dilated, irregular, and calcified; intraductal protein plugs and stones are typical in alcoholic chronic pancreatitis.
• Exocrine insufficiency develops first (leading to malabsorption and steatorrhea), followed later by endocrine insufficiency (secondary diabetes mellitus, often termed “type 3c diabetes”).
• Chronic inflammation and architectural distortion increase the risk of pancreatic carcinoma over time.

Clinical Presentation

Acute Pancreatitis

The classic presentation is acute onset of severe epigastric pain radiating to the back.

• Pain: sudden, severe, constant epigastric or left upper quadrant pain; may radiate to the back or chest; often relieved somewhat by leaning forward or sitting up and worsened by supine position.
• GI symptoms: nausea, vomiting, anorexia, abdominal distension, ileus.
• Systemic signs: tachycardia, fever, hypotension, tachypnea; in severe cases, signs of shock or respiratory distress (acute respiratory distress syndrome).
• Physical examination: epigastric tenderness, guarding; decreased or absent bowel sounds due to ileus; occasionally mild jaundice in gallstone pancreatitis.
• Severe disease signs:
  • Grey Turner sign: flank ecchymoses due to retroperitoneal hemorrhage.
  • Cullen sign: periumbilical ecchymoses.
  • These are late and associated with severe necrotizing pancreatitis.

Chronic Pancreatitis

Chronic pancreatitis presents with more insidious and recurrent symptoms:

• Chronic or recurrent epigastric pain: often radiating to the back; may be exacerbated by meals or alcohol; can become less prominent as the pancreas “burns out.”
• Malabsorption: steatorrhea (bulky, foul-smelling, oily stools), weight loss, fat-soluble vitamin deficiencies (A, D, E, K) once >90% of exocrine function is lost.
• Endocrine insufficiency: diabetes mellitus with labile blood sugars and increased risk of hypoglycemia due to simultaneous loss of α and β cells.
• Other features: jaundice from bile duct compression, recurrent pancreatitis episodes, or complications such as pseudocyst or biliary obstruction.

Diagnostic Evaluation

Diagnostic Criteria for Acute Pancreatitis

Diagnosis of acute pancreatitis generally requires at least 2 of 3 criteria:

• Characteristic abdominal pain consistent with acute pancreatitis.
• Serum amylase and/or lipase levels > 3 times upper limit of normal (lipase preferred).
• Imaging (usually CT, MRI, or ultrasound) findings consistent with pancreatitis.

Laboratory Tests

• Serum lipase: more specific and remains elevated longer than amylase; typically > 3× ULN in acute pancreatitis.
• Serum amylase: also elevated but less specific (can increase in salivary disease, intestinal ischemia, etc.).
• CBC: leukocytosis may be present.
• Metabolic panel: elevated BUN/creatinine, hypocalcemia (due to fat saponification), elevated liver enzymes and bilirubin in gallstone pancreatitis.
• Lipid panel: evaluate for hypertriglyceridemia.
• Serology: autoimmune markers (e.g., IgG4) if autoimmune pancreatitis suspected.

Imaging in Acute Pancreatitis

• Transabdominal ultrasound: first-line to evaluate for gallstones and biliary tract pathology; pancreas itself may not be well visualized due to overlying bowel gas.
• Contrast-enhanced CT (CECT): best for assessing severity, necrosis, and complications; typically reserved for uncertain diagnosis or clinical deterioration, often after 48–72 hours when necrosis becomes better defined.
• MRI/MRCP: useful alternative to CT; MRCP is excellent for visualizing biliary and pancreatic ducts, particularly in suspected choledocholithiasis or pancreatic ductal abnormalities.
• Endoscopic ultrasound (EUS): high-resolution assessment of the pancreas and biliary tree; often used when gallstones or sludge are suspected but not seen on transabdominal ultrasound.

Assessing Severity in Acute Pancreatitis

Severity stratification helps predict complications and guide level of care.

• Revised Atlanta Classification:
  • Mild: no organ failure, no local or systemic complications.
  • Moderately severe: transient organ failure (<48 hours) and/or local or systemic complications.
  • Severe: persistent organ failure (>48 hours), often involving multiple organs.
• Scoring systems: e.g., BISAP score, Ranson criteria, APACHE II, used early to estimate risk of severe disease.

Diagnosis of Chronic Pancreatitis

Diagnosis of chronic pancreatitis may be challenging and often relies on imaging along with clinical context.

• Clinical: chronic epigastric pain, steatorrhea, weight loss, history of alcohol use or recurrent acute pancreatitis.
• Imaging:
  • CT scan: pancreatic calcifications, ductal dilatation, gland atrophy, and irregular contour.
  • MRCP: detailed visualization of pancreatic ducts; can show strictures, dilatation, and side-branch changes.
  • Endoscopic retrograde cholangiopancreatography (ERCP): previously a gold standard but now used more for therapeutic purposes; demonstrates “chain of lakes” appearance of irregular ducts.
  • Endoscopic ultrasound (EUS): sensitive for early parenchymal and ductal changes.
• Functional tests: direct tests (e.g., secretin stimulation) or indirect tests (e.g., fecal elastase <200 μg/g) to assess exocrine insufficiency.

Management of Acute Pancreatitis

Initial Resuscitation and Supportive Care

Early, aggressive supportive care is the cornerstone of acute pancreatitis management.

• Fluid resuscitation:
  • Early isotonic crystalloid (e.g., lactated Ringer’s) to maintain intravascular volume and perfusion, especially within the first 24 hours.
  • Target urine output >0.5 mL/kg/hour and monitor BUN, hematocrit, and vital signs to guide therapy.
• Pain control: opioids are commonly required; use IV opioids and adjust based on pain and respiratory status.
• NPO initially: to rest the pancreas in the early phase, but prolonged fasting should be avoided.
• Early enteral nutrition: start oral or enteral feeding (nasogastric or nasojejunal) as soon as pain and vomiting improve, often within 24–48 hours; early feeding reduces infectious complications and organ failure compared with prolonged TPN.
• Monitoring: close observation of vital signs, urine output, oxygen saturation, and laboratory markers; higher level of care (ICU) for severe cases or organ failure.

Etiology-Specific Management

• Gallstone pancreatitis:
  • If associated with cholangitis or ongoing biliary obstruction (e.g., rising bilirubin, dilated bile duct), perform early ERCP with sphincterotomy (ideally within 24 hours).
  • Once acute episode stabilizes, plan cholecystectomy during the same hospitalization for mild disease to prevent recurrence.
• Alcohol-related pancreatitis: alcohol cessation counseling, treatment for alcohol use disorder, and nutritional support.
• Hypertriglyceridemia-induced: control triglycerides with insulin infusion, heparin (in some settings), and/or plasmapheresis if extremely elevated with severe disease; initiate long-term lipid-lowering therapy and lifestyle modification.
• Drug-induced: discontinue offending agent; avoid re-exposure.
• Autoimmune pancreatitis: often responsive to corticosteroids after malignancy is excluded.

Role of Antibiotics and Procedures

• Antibiotics:
  • Prophylactic antibiotics are not recommended in sterile necrotizing pancreatitis.
  • Use antibiotics only for confirmed or strongly suspected infection (e.g., infected necrosis, cholangitis, pneumonia, UTI), guided by cultures when possible.
• Management of necrosis and pseudocysts:
  • Most sterile collections are managed conservatively.
  • Infected necrosis or symptomatic necrotic collections may require drainage: endoscopic, percutaneous, or minimally invasive surgical approaches.
  • Asymptomatic pseudocysts can often be observed; intervene if large, symptomatic, infected, or causing obstruction.

Management of Chronic Pancreatitis

Lifestyle and Etiologic Treatment

• Alcohol and smoking cessation: both accelerate disease progression and increase pain and pancreatic cancer risk; strong counseling and support are essential.
• Dietary modification: small, frequent, low-fat meals to reduce pancreatic stimulation and improve symptoms.
• Treat underlying causes: autoimmune disease (steroids, immunosuppressants), ductal obstruction (endoscopic or surgical decompression), genetic counseling where indicated.

Pain Management

• Stepwise analgesia: begin with non-opioid analgesics (e.g., acetaminophen, NSAIDs where appropriate), then escalate to weak and strong opioids if needed, balancing efficacy with risk of dependence.
• Adjuvants: tricyclic antidepressants, gabapentinoids, or SNRIs for neuropathic pain components.
• Pancreatic enzyme supplementation: in some patients, enzyme replacement may reduce pain by decreasing pancreatic stimulation via feedback inhibition of cholecystokinin, though evidence is mixed; more clearly indicated for malabsorption.
• Interventional approaches: celiac plexus block, endoscopic therapy (e.g., duct stenting), or surgery (e.g., Puestow procedure for ductal decompression, pancreatectomy) for refractory pain or structural disease.

Treatment of Exocrine and Endocrine Insufficiency

• Pancreatic enzyme replacement therapy (PERT):
  • Enteric-coated pancrelipase preparations with meals and snacks to treat steatorrhea and malabsorption.
  • Typical starting doses adjusted by lipase units per meal, with titration based on symptom control and nutritional status.
• Nutritional support: high-calorie diet, vitamin supplementation (especially fat-soluble vitamins), and management of protein-energy malnutrition.
• Diabetes management: insulin is often required; management can be challenging due to combined insulin and glucagon deficiency, requiring careful monitoring for hypoglycemia.

Complications

Complications of Acute Pancreatitis

• Local complications:
  • Acute peripancreatic fluid collections.
  • Pancreatic pseudocyst (encapsulated fluid collection with a well-defined wall, lacking an epithelial lining).
  • Acute necrotic collections and walled-off necrosis.
  • Hemorrhage, pseudoaneurysm formation, splenic vein thrombosis, gastric outlet obstruction, colonic necrosis.
• Systemic complications:
  • Systemic inflammatory response syndrome (SIRS) and multiorgan failure.
  • Acute respiratory distress syndrome (ARDS), pleural effusions.
  • Acute kidney injury, shock, disseminated intravascular coagulation.
  • Sepsis, especially with infected necrosis.

Complications of Chronic Pancreatitis

• Chronic pain and opioid dependence.
• Pancreatic exocrine insufficiency (malabsorption, steatorrhea, weight loss, vitamin deficiencies).
• Endocrine insufficiency (diabetes mellitus).
• Pancreatic pseudocysts and ductal strictures.
• Biliary obstruction and cholestasis.
• Splenic vein thrombosis and portal hypertension.
• Increased risk of pancreatic adenocarcinoma.

Prognosis

The prognosis of pancreatitis depends on severity, etiology, and presence of complications.

• Acute pancreatitis: most cases are mild and self-limited with full recovery; severe cases with necrosis and organ failure carry significant mortality, especially when infected necrosis or persistent organ failure occurs.
• Chronic pancreatitis: progressive disease with irreversible structural damage; prognosis is influenced by ongoing alcohol and tobacco use, nutritional status, and development of complications such as diabetes and pancreatic cancer.

Key Clinical Pearls and Exam Tips

• Gallstones and alcohol are the two most important causes of acute pancreatitis; always look for a history of biliary colic and alcohol use.
• Acute pancreatitis diagnosis: need 2 of 3 – characteristic pain, elevated lipase/amylase > 3× ULN, and imaging findings.
• Lipase is more specific than amylase and stays elevated longer; exam questions commonly highlight this point.
• Pain that is epigastric, severe, postprandial, and radiating to the back with improvement when leaning forward is classic for pancreatitis.
• Early management of acute pancreatitis: aggressive IV fluids (often LR), adequate analgesia, and early enteral feeding once tolerated; avoid unnecessary TPN.
• Do not give prophylactic antibiotics in sterile necrotizing pancreatitis; reserve antibiotics for suspected or proven infection.
• Gallstone pancreatitis with evidence of cholangitis or ongoing obstruction should trigger early ERCP with sphincterotomy.
• Grey Turner and Cullen signs suggest severe hemorrhagic pancreatitis; these are high-yield but late findings.
• Hypocalcemia in acute pancreatitis (due to fat saponification) may correlate with more severe disease.
• Chronic pancreatitis: think of a middle-aged person with chronic alcohol use, recurrent epigastric pain, weight loss, and steatorrhea; imaging may show pancreatic calcifications.
• Chronic pancreatitis frequently leads to exocrine insufficiency (steatorrhea, fat-soluble vitamin deficiency) and endocrine insufficiency (diabetes).
• Pancreatic enzyme replacement is the mainstay for malabsorption in chronic pancreatitis and can sometimes help with pain.
• Both alcohol and smoking cessation are crucial in slowing progression of chronic pancreatitis and reducing cancer risk.
• On exams, hypertriglyceridemia-induced pancreatitis is suggested by a history of very high triglycerides and can present with milky serum.

Summary

Pancreatitis is a spectrum of pancreatic inflammatory disease ranging from self-limited acute episodes to chronic, irreversible damage with major nutritional and metabolic consequences. For medical students and exam preparation, focus on recognizing classic presentations, the major etiologies (gallstones and alcohol), diagnostic criteria, key laboratory and imaging findings, and early management priorities such as fluid resuscitation, pain control, and addressing the underlying cause. Understanding the progression from acute to chronic disease and the associated complications (pseudocysts, necrosis, diabetes, exocrine insufficiency, and increased cancer risk) is crucial for both clinical care and high-yield exam performance.